Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $210 | In Stock | |
5 mg | $520 | In Stock | |
10 mg | $753 | In Stock | |
25 mg | $1,160 | In Stock | |
50 mg | $1,570 | In Stock | |
100 mg | $2,120 | In Stock | |
500 mg | $4,250 | In Stock |
Description | Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis. |
In vivo | Dersalazine sodium (DS) (10 or 30 mg/kg; b.i.d.; rats), when administered for 7 days, showed intestinal anti-inflammatory effects in TNBS-induced colitis; these effects were observed both macroscopically and through the profile of inflammatory mediators (TNF, IL-1β, IL-6, and IL-17). Although the 2 day treatment with DS did not induce intestinal anti-inflammatory effects, it was sufficient to reduce the enhanced IL-17 expression. DS showed beneficial effects on DSS-induced colitis in C57BL/6 mice and reduced colonic pro-inflammatory cytokines IL-1β, IL-6, and IL-17.[2] |
Alias | Dersalazine Free Base |
Molecular Weight | 600.67 |
Formula | C35H32N6O4 |
Cas No. | 188913-58-8 |
Storage | Shipping with blue ice. |
Solubility Information | DMSO: < 1 mg/mL (insoluble) |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.